Truist Securities Reiterates Buy on PROCEPT BioRobotics, Lowers Price Target to $74
Truist Securities Reiterates Buy on PROCEPT BioRobotics, Lowers Price Target to $74
Truist Securities重申買入PROCEPT BioRobotics,將目標價格下調至74美元。
Truist Securities analyst Richard Newitter reiterates PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price target from $79 to $74.
Truist Securities分析師Richard Newitter重申買入PROCEPt BioRobotics (NASDAQ:PRCT),並將目標價從79美元降至74美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。